EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Quantification of serum elastase inhibitory activity in patients with pulmonary emphysema with and without alpha-1 antitrypsin deficiency

Gerard Orriols, Cristina Aljama, Francisco Rodriguez-Frias, Pablo-Gabriel Medina, Roser Ferrer-Costa iD, Galo Granados iD, Alexa Nuñez, Ane López-González, Gerardo Ruiz-Satelinas, Marc Miravitlles iD, Miriam Barrecheguren, Cristina Esquinas

PLOS One · 2025

DOI: 10.1371/journal.pone.0324237 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Gerard Orriols und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pneumology, Hospital Universitari Vall d'Hebron/ Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barc…. Hauptthemen laut MEDLINE: alpha 1-Antitrypsin Deficiency, Pulmonary Emphysema, alpha 1-Antitrypsin, Pancreatic Elastase. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundacio Catalana de Pneumologia (FUCAP), beca FUCAP-Grifols, Fundació Catalana de Pneumologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary emphysema, a component of chronic obstructive pulmonary disease (COPD) is characterised by irreversible alveolar tissue destruction and is produced by an imbalance between proteolytic enzymes, mostly neutrophil elastase (NE), and its inhibitors, mainly alpha-1 antitrypsin (AAT). We measured elastase-inhibitory activity (EIA) in serum samples and determined whether there is an association between EIA and COPD severity. This cross-sectional study recruited COPD patients with and without severe alpha-1 antitrypsin deficiency (AATD) and healthy controls. A semi-automated method assessed EIA using a porcine elastase inhibition assay. EIA levels and the EIA/AAT ratio were compared across groups and the correlation with clinical variables was analysed. A total of 86 individuals were recruited: 36 COPD patients, 20 individuals with COPD associated with AATD (Pi*ZZ mutation), of whom 11 were on augmentation therapy, and 30 healthy controls. Positive, linear and significant relationships were observed between EIA and AAT levels. The EIA/AAT ratio was higher in non AATD-related COPD patients compared to untreated Pi*ZZ patients and controls. Further analysis in non-AATD-related COPD patients revealed a higher EIA/AAT ratio associated with older age, higher comorbidity burden and a trend towards higher severity of lung disease. The strong correlation between AAT levels and EIA suggests that the assay technique employed is robust and effective for assessing EIA. The EIA assay may serve as a potential biomarker for the assessment of the severity and prognosis of emphysema.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha 1-Antitrypsin DeficiencyPulmonary Emphysemaalpha 1-AntitrypsinPancreatic ElastaseLeukocyte ElastaseHumansMaleFemaleMiddle AgedAgedPulmonary Disease, Chronic ObstructiveCross-Sectional StudiesCase-Control Studies

Substanzen

alpha 1-AntitrypsinPancreatic ElastaseLeukocyte Elastase

Autor:innen und Institutionen

  • Department of Pneumology, Hospital Universitari Vall d'Hebron/ Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Department of Basic Sciences, Universitat Internacional de Catalunya, Barcelona, Spain.
  • Clinical Biochemistry Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Liver Unit, Hospital Universitari Vall d´Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Department of Clinical Biochemistry, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.

ORCID-Profile: Roser Ferrer-Costa, Galo Granados, Marc Miravitlles

Förderung

  • Fundacio Catalana de Pneumologia (FUCAP), beca FUCAP-Grifols
  • Fundació Catalana de Pneumologia

Zitieren

APA

Orriols, G., Aljama, C., Rodriguez-Frias, F., Medina, P. G., Ferrer-Costa, R., Granados, G., Nuñez, A., López-González, A., Ruiz-Satelinas, G., Miravitlles, M., Barrecheguren, M., & Esquinas, C. (2025). Quantification of serum elastase inhibitory activity in patients with pulmonary emphysema with and without alpha-1 antitrypsin deficiency. PLOS One. https://doi.org/10.1371/journal.pone.0324237

Vancouver

Orriols G, Aljama C, Rodriguez-Frias F, Medina PG, Ferrer-Costa R, Granados G, et al. Quantification of serum elastase inhibitory activity in patients with pulmonary emphysema with and without alpha-1 antitrypsin deficiency. PLOS One. 2025. doi:10.1371/journal.pone.0324237

BibTeX
@article{Orriols2025,
  author = {Orriols, Gerard and Aljama, Cristina and Rodriguez-Frias, Francisco and Medina, Pablo-Gabriel and Ferrer-Costa, Roser and Granados, Galo and Nuñez, Alexa and López-González, Ane and Ruiz-Satelinas, Gerardo and Miravitlles, Marc and Barrecheguren, Miriam and Esquinas, Cristina},
  title = {Quantification of serum elastase inhibitory activity in patients with pulmonary emphysema with and without alpha-1 antitrypsin deficiency},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0324237}
}
Kostenlos starten →